Literature DB >> 28511259

Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.

Alexander M Lopez1, Daniel Weintraub2, Daniel O Claassen3.   

Abstract

Impulsive and compulsive behaviors in Parkinson's disease (PD) patients are most often attributed to dopamine agonist therapy; dysregulation of the mesocorticolimbic system accounts for this behavioral phenotype. The clinical presentation is commonly termed impulse control disorder (ICD): Behaviors include hypersexuality, compulsive eating, shopping, pathological gambling, and compulsive hobby participation. However, not all PD individuals taking dopamine agonists develop these behavioral changes. In this review, the authors focus on the similarities between the phenotypic presentation of ICDs with that of other reward-based behavioral disorders, including binge eating disorder, pathological gambling, and substance use disorders. With this comparison, we emphasize that the transition from an impulsive to compulsive behavior likely follows a ventral to dorsal striatal pattern, where an altered dopaminergic reward system underlies the emergence of these problematic behaviors. The authors discuss the neurobiological similarities between these latter disorders and ICDs, emphasizing similar pathophysiological processes and discussing treatment options that have potential for translation to PD patients. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28511259      PMCID: PMC5516267          DOI: 10.1055/s-0037-1601887

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  87 in total

1.  Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior.

Authors:  Takatoshi Hikida; Kensuke Kimura; Norio Wada; Kazuo Funabiki; Shigetada Nakanishi
Journal:  Neuron       Date:  2010-06-24       Impact factor: 17.173

Review 2.  Reward processing by the lateral habenula in normal and depressive behaviors.

Authors:  Christophe D Proulx; Okihide Hikosaka; Roberto Malinow
Journal:  Nat Neurosci       Date:  2014-09       Impact factor: 24.884

Review 3.  Treatment of pathological gambling.

Authors:  Kit Sang Leung; Linda B Cottler
Journal:  Curr Opin Psychiatry       Date:  2009-01       Impact factor: 4.741

4.  The habenula encodes negative motivational value associated with primary punishment in humans.

Authors:  Rebecca P Lawson; Ben Seymour; Eleanor Loh; Antoine Lutti; Raymond J Dolan; Peter Dayan; Nikolaus Weiskopf; Jonathan P Roiser
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

5.  Dopamine-related personality traits in Parkinson's disease.

Authors:  M A Menza; L I Golbe; R A Cody; N E Forman
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

6.  SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder.

Authors:  Thomas Rinne; Wim van den Brink; Luuk Wouters; Richard van Dyck
Journal:  Am J Psychiatry       Date:  2002-12       Impact factor: 18.112

7.  Dopamine transporter gene (DAT1) associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder.

Authors:  Caroline Davis; Robert D Levitan; Allan S Kaplan; Jacqueline Carter; Caroline Reid; Claire Curtis; Karen Patte; James L Kennedy
Journal:  Neuropsychopharmacology       Date:  2007-02-21       Impact factor: 7.853

8.  Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity.

Authors:  M Zack; C X Poulos
Journal:  J Psychopharmacol       Date:  2008-06-26       Impact factor: 4.153

9.  Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions.

Authors:  G R Uhl; J C Hedreen; D L Price
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

10.  Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects.

Authors:  Polyvios Demetriades; Hugh Rickards; Andrea Eugenio Cavanna
Journal:  Parkinsons Dis       Date:  2011-02-20
View more
  7 in total

1.  Compulsive eating behaviors in Parkinson's disease.

Authors:  Ingrid de Chazeron; Franck Durif; Isabelle Chereau-Boudet; Maria Livia Fantini; Ana Marques; Philippe Derost; Berengere Debilly; Georges Brousse; Yves Boirie; Pierre Michel Llorca
Journal:  Eat Weight Disord       Date:  2019-02-04       Impact factor: 4.652

2.  White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Impulse Control Disorders.

Authors:  Mahtab Mojtahed Zadeh; Amir Ashraf-Ganjouei; Farzaneh Ghazi Sherbaf; Maryam Haghshomar; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-03-20       Impact factor: 4.003

Review 3.  Disruption of Inferior Longitudinal Fasciculus Microstructure in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies.

Authors:  Maryam Haghshomar; Mahsa Dolatshahi; Farzaneh Ghazi Sherbaf; Hossein Sanjari Moghaddam; Mehdi Shirin Shandiz; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-07-26       Impact factor: 4.003

Review 4.  Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease.

Authors:  Robert S Eisinger; Adolfo Ramirez-Zamora; Samuel Carbunaru; Brandon Ptak; Zhongxing Peng-Chen; Michael S Okun; Aysegul Gunduz
Journal:  Front Neurol       Date:  2019-02-26       Impact factor: 4.003

5.  Pathological gambling in a patient on piribedil: A case report.

Authors:  Yingtan Wang; Zhe Lu; Guanglei Xun
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

6.  Impulse Control Disorders in Parkinson's Disease. A Brief and Comprehensive Review.

Authors:  Emilia M Gatto; Victoria Aldinio
Journal:  Front Neurol       Date:  2019-04-17       Impact factor: 4.003

7.  Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson's Disease.

Authors:  Cang Chen; Michael J Guderyon; Yang Li; Guo Ge; Anindita Bhattacharjee; Cori Ballard; Zhixu He; Eliezer Masliah; Robert A Clark; Jason C O'Connor; Senlin Li
Journal:  Mol Ther Methods Clin Dev       Date:  2019-11-26       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.